AlphaCrest Capital Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,235
Closed -$1.02M 884
2022
Q3
$1.02M Sell
14,235
-8,982
-39% -$804K 0.06% 598
2022
Q2
$2.26M Buy
23,217
+14,959
+181% +$1.52M 0.11% 268
2022
Q1
$929K Buy
8,258
+4,544
+122% +$484K 0.05% 587
2021
Q4
$501K Buy
3,714
+283
+8% +$39.4K 0.02% 1098
2021
Q3
$484K Sell
3,431
-7,284
-68% -$979K 0.03% 927
2021
Q2
$1.37M Sell
10,715
-5,598
-34% -$659K 0.06% 512
2021
Q1
$2.09M Buy
16,313
+10,710
+191% +$1.98M 0.12% 240
2020
Q4
$1.01M Buy
5,603
+4,554
+434% +$1.01M 0.08% 313
2020
Q3
$230K Buy
+1,049
New +$234K 0.03% 991
2020
Q1
Sell
-3,698
Closed -$277K 1231
2019
Q4
$277K Sell
3,698
-3,402
-48% -$220K 0.02% 1102
2019
Q3
$436K Sell
7,100
-100
-1% -$6.02K 0.03% 977
2019
Q2
$427K Sell
7,200
-2,800
-28% -$168K 0.04% 758
2019
Q1
$655K Buy
+10,000
New +$605K 0.1% 355

Other funds holding QDEL

AlphaCrest Capital Management's QDEL Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of QuidelOrtho (QDEL) in Q4 2022, closing a stake of 14,235 shares — an estimated $1.02M sold.

AlphaCrest Capital Management first reported a position in QDEL in Q1 2019 and held it in 13 quarters. The position peaked at $2.26M in Q2 2022. 347 funds tracked by Wall St. Rank hold QDEL as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining QuidelOrtho position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 14,235 QuidelOrtho shares in Q4 2022, an estimated $1.02M.
  • AlphaCrest Capital Management first reported a position in QuidelOrtho in Q1 2019 and held it in 13 quarters.
  • AlphaCrest Capital Management's QuidelOrtho position peaked at $2.26M in Q2 2022.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.